Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review

References

• Abdollahi E, Tavasolian F, Ghasemi N, Mirghanizadeh SA, Azizi M, Ghoryani M, Samadi M. 2015. Association between lower frequency of R381Q variant (rs11209026) in IL-23 receptor gene and increased risk of recurrent spontaneous abortion (RSA). J Immunotoxicol. 12:317–321
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho J. 2009. IL‐23/TH17 pathways and inflammatory bowel disease. Inflamm Bowel Dis. 15:1090–1100.
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. IL-1β and -6, but not TGFβ are essential for the differentiation of IL-17-producing human T-helper cells. Nat Immunol. 8:942–949.
   PubMed Web of Science ®Google Scholar
• Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F. 2010. IL-23 drives intestinal inflammation through direct activity on T-cells. Immunity. 33:279–288.
   PubMed Web of Science ®Google Scholar
• Altshuler D, Daly MJ, Lander ES. 2008. Genetic mapping in human disease. Science. 322:881–888.
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali F. 2007. Phenotypic and functional features of human TH17 cells. J Exp Med. 204:1849–1861.
   PubMed Web of Science ®Google Scholar
• Arjmand F, Samadi M. 2016. Association of 14-bp insertion/deletion polymorphism of HLA-G gene with idiopathic recurrent miscarriages in infertility center patients in Yazd, Iran. J Immunotoxicol. 13:249–254.
   PubMed Web of Science ®Google Scholar
• Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, Frackelton EC, Otieno FG, Kanterakis S, Shaner JL. 2007. Association of variants of the IL–23 receptor gene with susceptibility to pediatric Crohn’s disease. Clin Gastroenterol Hepatol. 5:972–976.
   PubMed Web of Science ®Google Scholar
• Baptista ML, Amarante H, Picheth G, Sdepanian VL, Peterson N, Babasukumar U, Lima HC, Kugathasan S. 2008. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Inflamm Bowel Dis. 14:674–679.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 40:955–962.
   PubMed Web of Science ®Google Scholar
• Becker C, Dornhoff H, Neufert C, Fantini M, Wirtz S, Huebner S, Nikolaev A, Lehr H, Murphy A, Valenzuela D. 2006. IL-23 cross-regulates IL-12 production in T-cell-dependent experimental colitis. J Immunol. 177:2760–2764.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. 2008. Induction and effector functions of TH17 cells. Nature. 453:1051–1057.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. 2007. TH17 cells in the circle of immunity and autoimmunity. Nat Immunol. 8:345–350.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blumenschein WM, Brovont-Porth K, McGeachy MJ, Basham B, Desai B, Pierce R, McClanahan TK, Sadekova S, de Waal Malefyt R. 2010. Human TH17 cells comprise heterogeneous subsets including IFNγ-producing cells with distinct properties from the TH1 lineage. J Immunol. 185:679–687.
   PubMed Web of Science ®Google Scholar
• Borgiani P, Perricone C, Ciccacci C, Romano S, Novelli G, Biancone L, Petruzziello C, Pallone F. 2007. IL-23R Arg381Gln is associated with suscepti–bility to Crohn’s disease but not with phenotype in an Italian population. Gastroenterology. 133:1049–1051.
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte J-M, Diepolder H, Marquardt A, Jagla W, Popp A. 2006. IL-22 is increased in active Crohn’s disease and promotes pro-inflammatory gene expression and intestinal epithelial cell migration. Am J Physiol. 290:G827–G838.
   PubMed Web of Science ®Google Scholar
• Büning C, Genschel J, Weltrich R, Lochs H, Schmidt H. 2003. The IL‐25 gene located in the inflammatory bowel disease (IBD) 4 region: No association with inflammatory bowel disease. Eur J Immunogen. 30:329–333.
   PubMedGoogle Scholar
• Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 447:661–678.
   PubMed Web of Science ®Google Scholar
• Capon F, di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD. 2007. Sequence variants in the genes for IL-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Human Genet. 122:201–206.
   PubMed Web of Science ®Google Scholar
• Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ. 2007. A large-scale genetic association study confirms IL-12B and leads to identification of IL23R as psoriasis-risk genes. Am J Human Genet. 80:273–290.
   PubMed Web of Science ®Google Scholar
• Chaligné R, Tonetti C, Besancenot R, Roy L, Marty C, Mossuz P, Kiladjian J-J, Socié G, Bordessoule D, Le Bousse-Kerdilès M-C. 2008. New mutations of MPL in primitive myelo-fibrosis: only MPL W515 mutations promote G1/S-phase transition. Leukemia. 22:1557–1566.
   PubMed Web of Science ®Google Scholar
• Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest. 116:1317–1326.
   PubMed Web of Science ®Google Scholar
• Cosmi L, de Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R. 2008. Human IL-17-producing cells originate from a CD161+CD4+ T-cell precursor. J Exp Med. 205:1903–1916.
   PubMed Web of Science ®Google Scholar
• Cotterill L, Payne D, Levison S, McLaughlin J, Wesley E, Feeney M, Durbin H, Lal S, Makin A, Campbell S. 2010. Replication and meta-analysis of 13,000 cases defines the risk for IL-23 receptor and autophagy-related 16-like 1 variants in Crohn’s disease. Canad J Gastroenterol. 24:297–305.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T. 2003. IL-23 rather than IL-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744–748.
   PubMed Web of Science ®Google Scholar
• Di Meglio P, Di Cesare A, Laggner U, Chu C-C, Napolitano L, Villanova F, Tosi I, Capon F, Trembath RC, Peris K. 2011. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PloS one. 6:e17160.
   PubMed Web of Science ®Google Scholar
• Duan Z, Pan F, Zeng Z, Zhang T, Wang S, Li G, Xu S, Xu J, Zhang L. 2012. IL-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Intl. 32:1209–1214.
   PubMed Web of Science ®Google Scholar
• Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A, Dutridge D, Wahbeh G, Silber G, Bahar R. 2007. IL‐23 receptor (IL‐23R) gene protects against pediatric Crohn's disease. Inflamm Bowel Dis. 13:511–515.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A. 2006. A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science. 314:1461–1463.
   PubMed Web of Science ®Google Scholar
• Elmaagacli A, Koldehoff M, Landt O, Beelen D. 2008. Relation of an IL-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant. 41:821–826.
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR. 2010. IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol Res Practice. 2010:1–12.
   Web of Science ®Google Scholar
• Fraser Cummings J, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. 2007. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis. 13:1063–1068.
   PubMed Web of Science ®Google Scholar
• Frucht DM. 2002. IL-23: a cytokine that acts on memory T-cells. Science Signaling. 2002:pe1.
   Google Scholar
• Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, Heller F, Neurath MF, Strober W, Mannon PJ. 2006. Both IL‐12p70 and IL‐23 are synthesized during active Crohn's disease and down‐regulated by treatment with anti‐IL‐12 p40 monoclonal antibody. Inflamm Bowel Dis. 12:9–15.
   PubMed Web of Science ®Google Scholar
• Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, Roma-Giannikou E. 2010. NOD2/CARD15, ATG16L1, and IL23R gene polymorphisms and childhood-onset of Crohn’s disease. World J Gastroenterol. 16:1753.
   PubMed Web of Science ®Google Scholar
• Glas J, Seiderer J, Wetzke M, Konrad A, Torok H-P, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S. 2007. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: Combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One. 2:e819.
   PubMed Web of Science ®Google Scholar
• Grigoras CA, Ziakas PD, Jayamani E, Mylonakis E. 2015. ATG16L1 and IL23R variants and genetic susceptibility to Crohn's Disease: Mode of inheritance based on meta-analysis of genetic association studies. Inflamm Bowel Dis. 21:768–776.
   PubMed Web of Science ®Google Scholar
• Guan Q, Ma Y, Aboud L, Weiss C, Qing G, Warrington R, Peng Z. 2012. Targeting IL‐23 by employing a p40 peptide‐based vaccine ameliorates murine allergic skin and airway inflammation. Clin Exp Allergy. 42:1397–1405.
   PubMed Web of Science ®Google Scholar
• Hamdy G, Darweesh H, Khattab EA, Fawzy S, Fawzy E, Sheta M. 2015. Evidence of association of IL-23 receptor gene polymorphisms with Egyptian rheumatoid arthritis patients. Human Immunol. 76:417–420.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. 2005. IL-17-producing CD4+ effector T-cells develop via a lineage distinct from the T-helper Type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
   PubMed Web of Science ®Google Scholar
• Hazlett J, Stamp L, Merriman T, Highton J, Hessian P. 2012. IL-23R rs11209026 poly-morphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun. 13:282–287.
   PubMed Web of Science ®Google Scholar
• Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C, Ceuppens JL. 2003. IL-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol. 28:42–50.
   PubMed Web of Science ®Google Scholar
• Hradsky O, Dusatkova P, Lenicek M, et al. 2010. The CTLA4 variants may interact with the IL23R-and NOD2-conferred risk in development of Crohn's disease. BMC Med Genet. 11:91.
   PubMed Web of Science ®Google Scholar
• Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. 2006. IL-23 drives innate and T-cell-mediated intestinal inflammation. J Exp Med. 203:2473–2483.
   PubMed Web of Science ®Google Scholar
• Kim H-R, Kim H-S, Park M-K, Cho M-L, Lee S-H, Kim H-Y. 2007. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand J Rheumatol. 36:259–264.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, de Waal Malefyt R. 2009. Circulating and gut-resident human TH17 cells express CD161 and promote intestinal inflammation. J Exp Med. 206:525–534.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and TH17 Cells. Ann Rev Immunol. 27:485–517.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH. 2009. Phenotype, distribution, generation, and functional and clinical relevance of TH17 cells in human tumor environments. Blood. 114:1141–1149.
   PubMed Web of Science ®Google Scholar
• Lacher M, Schroepf S, Helmbrecht J, Von Schweinitz D, Ballauff A, Koch I, Lohse P, Osterrieder S, Kappler R, Koletzko S. 2010. Association of the IL‐23 receptor gene variant rs11209026 with Crohn’s disease in German children. Acta Paediatr. 99:727–733.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Szamosi T, Szilvási A, Molnar E, Lakatos L, Kovacs A, Molnár T, Altorjay I, Papp M, Tulassay Z. 2008. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Digest Liver Dis. 40:867–873.
   Web of Science ®Google Scholar
• Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG. 2004. Increased expression of IL-23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 199:125–130.
   PubMed Web of Science ®Google Scholar
• Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB, Investigators PS. 2008. Efficacy and safety of ustekinumab, a human IL-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized double-blind placebo-controlled trial (PHOENIX 1). Lancet. 371:1665–1674.
   PubMed Web of Science ®Google Scholar
• Lerch-Bader M, Lundin C, Kim H, Nilsson I, von Heijne G. 2008. Contribution of positively charged flanking residues to the insertion of trans-membrane helices into the endoplasmic reticulum. Proc Natl Acad Sci USA. 105:4127–4132.
   PubMed Web of Science ®Google Scholar
• Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D, Vermeire S, Dewit O, De Vos M, Dixon A. 2007. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3:e58.
   PubMed Web of Science ®Google Scholar
• Magyari L, Melyaregu G, Melegh B. 2008. Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients. Orvosi Hetilap. 150:81–88.
   Google Scholar
• Manel N, Unutmaz D, Littman DR. 2008. Differentiation of human TH17 cells requires TGFβ and induction of the nuclear receptor RORγt. Nat Immunol. 9:641–649.
   PubMed Web of Science ®Google Scholar
• Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL. 2004. Anti-IL-12 antibody for active Crohn's disease. New Engl J Med. 351:2069–2079.
   PubMed Web of Science ®Google Scholar
• McGovern D, Powrie F. 2007. The IL23 axis plays a key role in the pathogenesis of IBD. Gut. 56:1333–1336.
   PubMed Web of Science ®Google Scholar
• Mosayebian A, Meshkat R, Ghasemi R, Samadi M. 2015. Association between IL-23 receptor R381Q gene polymorphism and asthma. Iran J Allergy Asthma Immunol. (in press).
   PubMed Web of Science ®Google Scholar
• Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ. 2003. Divergent pro-and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 198:1951–1957.
   PubMed Web of Science ®Google Scholar
• Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang S-K. 2005. IL-17F induces pulmonary neutrophilia and amplifies antigen–induced allergic response. Am J Respir Crit Care Med. 171:12–18.
   PubMed Web of Science ®Google Scholar
• Oliver J, Rueda B, Lopez-Nevot MA, Gómez–García M, Martín J. 2007. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease. Clin Gastroenterol Hepatol. 5:977–981.
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715–725.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. 2008. Biological functions of TH17 cell effector cytokines in inflammation. Immunity. 28:454–467.
   PubMed Web of Science ®Google Scholar
• Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 168:5699–5708.
   PubMed Web of Science ®Google Scholar
• Pidasheva S, Trifari S, Phillips A, Hackney JA, Ma Y, Smith A, Sohn SJ, Spits H, Little RD, Behrens TW. 2011. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One. 6:e25038.
   PubMed Web of Science ®Google Scholar
• Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. 2008. Association of IL‐23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58:1020–1025.
   PubMed Web of Science ®Google Scholar
• Raymond YY, Brazaitis J, Gallagher G. 2015. The human IL-23 Receptor rs11209026 A allele promotes the expression of a soluble IL-23R-encoding mRNA apecies. J Immunol. 194:1062–1068.
   PubMed Web of Science ®Google Scholar
• Roberts RL, Gearry RB, Hollis Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR. 2007. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol. 102:2754–2761.
   PubMed Web of Science ®Google Scholar
• Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, González-Gay MA, Martin J. 2008. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis. 67:1451–1454.
   PubMed Web of Science ®Google Scholar
• Safrany E, Melegh B. 2009. Functional variants of the IL-23 receptor gene in non-gastrointestinal autoimmune diseases. Cur Med Chem. 16:3766–3774.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P, Group UCsDS. 2008. A randomized trial of Ustekinumab, a human IL-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology. 135:1130–1141.
   PubMed Web of Science ®Google Scholar
• Sarin R, Wu X, Abraham C. 2011. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci USA. 108:9560–9565.
   PubMed Web of Science ®Google Scholar
• Schindler C, Plumlee C, editors. 2008. Inteferons open the JAK-STAT pathway. In: Seminars in cell and developmental biology. Amsterdam: Elsevier. p 311–318.
   Google Scholar
• Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A. 2005. Expression of IL‐12‐related cytokine transcripts in inflammatory bowel disease: elevated IL‐23p19 and IL‐27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis. 11:16–23.
   PubMed Web of Science ®Google Scholar
• Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A. 2008. Role of the novel TH17 cytokine IL‐17F in inflammatory bowel disease (IBD): up-regulated colonic IL‐17F expression in active Crohn's disease and analysis of the IL17F p. His161Arg polymorphism in IBD. Inflamm Bowel Dis. 14:437–445.
   PubMed Web of Science ®Google Scholar
• Stevic MS, Stefanic M, Tokic S, Glavas-Obrovac L, Mihaljevic S, Karner I. 2014. Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto’s thyroiditis in the Croatian population. Endocrine Res. 39:164–167.
   PubMed Web of Science ®Google Scholar
• Tavasolian F, Abdollahi E, Samadi M. 2014. Association of the IL4R single-nucleotide polymorphism I50V with recurrent spontaneous abortion (RSA). J Assisted Repro Genet. 31:851–856.
   PubMed Web of Science ®Google Scholar
• Tonel G, Conrad C, Laggner U, Di Meglio P, Grys K, McClanahan TK, Blumenschein WM, Qin J-Z, Xin H, Oldham E. 2010. Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol. 185:5688–5691.
   PubMed Web of Science ®Google Scholar
• Torti DC, Feldman SR. 2007. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol. 57:1059–1068.
   PubMed Web of Science ®Google Scholar
• Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ. 2007. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology. 132:1657–1664.
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Pflanz S, Kastelein RA. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T-cell responses. Immunity. 19:641–644.
   PubMed Web of Science ®Google Scholar
• van de Vosse E, Hoeve MA, Ottenhoff TH. 2004. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis. 4:739–749.
   PubMed Web of Science ®Google Scholar
• Venegas M, Beltrán CJ, Álvarez L, Castro A, Torres T, Leal AD, Lahsen FM, Hermoso MA, Quera R. 2008. IL-23R Arg381Gln polymorphism in Chilean patients with inflammatory bowel disease. Eur Cytokine Netw. 19:190–195.
   PubMed Web of Science ®Google Scholar
• Volpe E, Servant N, Zollinger R, Bogiatzi SI, BarHupé P, Barillot E, Soumelis V. 2008. A critical function for TGFβ, IL-23, and pro-inflammatory cytokines in driving and modulating human TH17 responses. Nat Immunol. 9:650–657.
   PubMed Web of Science ®Google Scholar
• Wang X, Lin Z, Wei Q, Jiang Y, Gu J. 2009. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Intl. 29:1343–1347.
   PubMed Web of Science ®Google Scholar
• Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, van Dullemen HM, Kleibeuker JH, Wijmenga C, Dijkstra G. 2008. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol. 103:621–627.
   PubMed Web of Science ®Google Scholar
• Wilke CM, Bishop K, Fox D, Zou W. 2011. Deciphering the role of TH17 cells in human disease. Trends Immunol. 32:603–611.
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F. 2007. Development, cytokine profile and function of human IL-17-producing helper T-cells. Nat Immunol. 8:950–957.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. 2007. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13. 1 loci with Crohn’s disease in Japanese patients. J Human Genet. 52:575–583.
   PubMed Web of Science ®Google Scholar
• Yu P, Shen F, Zhang X, Cao R, Zhao X, Liu P, Tu H, Yang X, Shi R, Zhang H. 2012. Association of single nucleotide polymorphisms of IL23R and IL-17 with ulcerative colitis risk in a Chinese Han population. PLoS One. 7:e44380.
   Google Scholar